Literature DB >> 4550321

Amantadine and levodopa in the treatment of Parkinson's disease.

J E Walker, A Potvin, W Tourtellotte, J Albers, B Repa, W Henderson, D Snyder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4550321     DOI: 10.1002/cpt197213128

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

1.  A battery of tests for evaluating steadiness in clinical trials.

Authors:  A R Potvin; J W Albers; R F Stribley; W W Tourtellotte; R W Pew
Journal:  Med Biol Eng       Date:  1975-11

2.  Portable clinical tracking-task instrument.

Authors:  A R Potvin; J A Doerr; J T Estes; W W Tourtellotte
Journal:  Med Biol Eng Comput       Date:  1977-07       Impact factor: 2.602

3.  Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa.

Authors:  L R Zeldowicz; J Hubermann
Journal:  Can Med Assoc J       Date:  1973-10-06       Impact factor: 8.262

4.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 5.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

Review 6.  NMDA receptors in clinical neurology: excitatory times ahead.

Authors:  Lorraine V Kalia; Suneil K Kalia; Michael W Salter
Journal:  Lancet Neurol       Date:  2008-08       Impact factor: 44.182

Review 7.  Amantadine in Parkinson's disease.

Authors:  N Crosby; K H Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.